taurolidine has been researched along with Hematologic Malignancies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar-Guisado, M; Albasanz-Puig, A; Arnan, M; Berbel, D; Carratalà, J; Cisneros, JM; Gudiol, C; Laporte-Amargós, J; Martín-Gandul, C; Montero, I; Nicolae, S; Perayre, M; Riera, J; Royo-Cebrecos, C; Sánchez-Ortega, I; Sureda, A; Tebe, C | 1 |
| Aguilar-Guisado, M; Arnan, M; Berbel, D; Carratalà, J; Cisneros-Herreros, JM; Encuentra, M; Gudiol, C; Martín-Gandul, C; Montero, I; Nicolae, S; Perayre, M; Royo-Cebrecos, C | 1 |
| Degenhardt, P; Dümichen, MJ; Ebell, W; Geffers, C; Kühl, JS; Lode, HN; Querfeld, U; Seeger, K; Singer, M | 1 |
| Bendiks, M; Göpel, W; Härtel, C; Herting, E; Kuhn, M; Lauten, M; Scholz, T | 1 |
| Funch, P; Fuursted, K; Handrup, MM; Møller, JK; Schrøder, H | 1 |
4 trial(s) available for taurolidine and Hematologic Malignancies
| Article | Year |
|---|---|
A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Citrates; Double-Blind Method; Female; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Neutropenia; Pharmaceutical Solutions; Prospective Studies; Taurine; Thiadiazines | 2020 |
Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Topics: Anti-Infective Agents; Antineoplastic Agents; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Central Venous Catheters; Citrates; Device Removal; Double-Blind Method; Equivalence Trials as Topic; Hematologic Neoplasms; Humans; Multicenter Studies as Topic; Neutropenia; Prospective Studies; Risk Factors; Spain; Taurine; Thiadiazines; Time Factors; Treatment Outcome | 2018 |
Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
Topics: Adolescent; Anti-Infective Agents, Local; Anticoagulants; Bacteria; Catheter-Related Infections; Catheterization; Catheters, Indwelling; Child; Child, Preschool; Female; Fever of Unknown Origin; Hematologic Neoplasms; Heparin; Humans; Incidence; Infant; Male; Survival Analysis; Taurine; Thiadiazines | 2012 |
Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Antineoplastic Agents; Bacterial Infections; Biofilms; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Female; Hematologic Neoplasms; Heparin; Humans; Infant; Male; Microscopy, Electron, Scanning; Prospective Studies; Taurine; Thiadiazines | 2012 |
1 other study(ies) available for taurolidine and Hematologic Malignancies
| Article | Year |
|---|---|
Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine.
Topics: Adult; Antineoplastic Agents; Cytokines; Female; Flow Cytometry; Hematologic Neoplasms; Humans; Immunity, Innate; Immunocompromised Host; Immunosuppression Therapy; Immunosuppressive Agents; Infant, Newborn; Leukocytes; Lipopolysaccharide Receptors; Male; Models, Theoretical; Stenotrophomonas maltophilia; Taurine; Thiadiazines | 2013 |